Search Results - "Karchava, M"

Refine Results
  1. 1

    COMPARATIVE STUDY OF FIB-4 INDEX AND TRANSIENT ELASTOGRAPHY AMONG PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION IN GEORGIA by Dolmazashvili, E, Karchava, M, Abutidze, A, Sharvadze, L, Tsertsvadze, T

    Published in Georgian medical news (01-03-2017)
    “…Liver biopsy remains the reference standard for fibrosis staging. However, it has several limitations, which have led to the development of non-invasive…”
    Get more information
    Journal Article
  2. 2

    Occurrence of occult HCV infection among Hiv infected patients in Georgia by Gatserelia, L, Sharvadze, L, Karchava, M, Dolmazashvili, E, Tsertsvadze, T

    Published in Georgian medical news (01-01-2014)
    “…Occult hepatitis C (OCI) infection has been known as detectable HCV-RNA in the liver or peripheral blood mononuclear cells (PBMCs) in the absence of detectable…”
    Get more information
    Journal Article
  3. 3

    MOLECULAR TRACING OF HETEROSEXUAL HIV-1 TRANSMISSION IN GEORGIA by Dvali, N, Chkhartishvili, N, Sharvadze, L, Karchava, M, Tsertsvadze, T

    Published in Georgian medical news (01-09-2015)
    “…HIV epidemic in Georgia has entered a new phase with number of heterosexually acquired infections rising each year. Epidemiological data indicates that this…”
    Get more information
    Journal Article
  4. 4

    Distinct drug resistance profile of HIV-1 subtype A strain circulating in Georgia by Dvali, N, Chkhartishvili, N, Karchava, M, Sharvadze, L, Tsertsvadze, T

    Published in Georgian medical news (01-03-2015)
    “…Emergence of HIV-1 drug resistance limits effectiveness of antiretroviral therapy (ART). Since 2004 Georgia provides free ART to all patients in need. We aimed…”
    Get more information
    Journal Article
  5. 5

    Discrepancy between HCV structural and non structural genes in Georgian genotype two patients by Tsertsvadze, T, Karchava, M, Sharvadze, L, Gatserelia, L, Dolmazashvili, E

    Published in Georgian medical news (01-10-2014)
    “…Correct identification of hepatitis C genotypes is an important diagnostic tool, which guarantees further selection of adequate treatment regimen and correct…”
    Get more information
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    HLA-B5701 genetic screening prior to abacavir prescription in Georgia by Dvali, N, Chkhartishvili, N, Sharvadze, L, Karchava, M, Tsertsvadze, T

    Published in Georgian medical news (01-12-2010)
    “…A hypersensitivity reaction to abacavir develops in approximately 2-8% of HIV patients receiving this drug and is strongly associated with presence of the…”
    Get more information
    Journal Article
  14. 14

    Prevailing HCV genotypes and subtypes among hiv infected patients in Georgia by Karchava, M, Sharvadze, L, Gatserelia, L, Badridze, N, Tsertsvadze, T

    Published in Georgian medical news (01-12-2009)
    “…Recent analysis of antiretroviral treatment (ART) program data in Georgia showed that end-stage liver disease was a leading cause of death among HIV/HCV co…”
    Get more information
    Journal Article
  15. 15

    Prevalence of HCV and genotypes distribution in general population of Georgia by Sharvadze, L, Nelson, Kenrad E, Imnadze, P, Karchava, M, Tsertsvadze, T

    Published in Georgian medical news (01-12-2008)
    “…The aim of four years study was to determine the prevalence of HCV infection in the general population of Georgia and to assess HCV genotypes spread among…”
    Get more information
    Journal Article
  16. 16

    Safety and efficacy of systematic administration of Filgrastim to prevent neutropenia and infections in patient with hepatitis C by Sharvadze, L, Karchava, M, Bolokadze, N, Gatserelia, L, Tsertsvadze, T

    Published in Georgian medical news (01-10-2009)
    “…The aim of 36 months follow up study was to assess the safety and efficacy of Filgrastim (Neupogen) for preventing neutropenia and bacterial infection during…”
    Get more information
    Journal Article
  17. 17

    Assessment of liver fibrosis and cirrhosis by transient elastography among patients with chronic HBV and HCV infection in Georgia by Tsertsvadze, T, Dolmazashvili, E, Abutidze, A, Sharvadze, L, Karchava, M

    Published in Georgian medical news (01-12-2008)
    “…The aim of the study was to evaluate liver fibrosis (LF) and cirrhosis using Transient elastography (TE) using Fibroscan in patients with chronic HBV and HCV…”
    Get more information
    Journal Article
  18. 18

    Distribution of HIV-1 resistant polymorphisms among HIV infected patients in Georgia by Karchava, M, Nelson, Kenrad E, Gochitashvili, N, Dvali, N, Tsertsvadze, T

    Published in Georgian medical news (01-12-2008)
    “…Host genetic factors are believed to play an important role in the pathogenesis and natural history of HIV disease along with determining the rate and severity…”
    Get more information
    Journal Article
  19. 19

    High incidence of the hepatitis C virus recombinant 2k/1b in Georgia: Recommendations for testing and treatment by Karchava, Marine, Waldenström, Jesper, Parker, Monica, Hallack, Renee, Sharvadze, Lali, Gatserelia, Lana, Chkhartishvili, Nikoloz, Dvali, Natia, Dzigua, Lela, Dolmazashvili, Ekaterine, Norder, Helene, Tsertsvadze, Tengiz

    Published in Hepatology research (01-12-2015)
    “…Aim The first hepatitis C virus (HCV) recombinant, RF2k/1b, was initially described from Russia and has since then been identified from patients in Ireland,…”
    Get full text
    Journal Article
  20. 20

    Prevalence of drug-resistance mutations and non-subtype B strains among HIV-infected infants from New York state by KARCHAVA, Marine, PULVER, Wendy, SMITH, Lou, PHILPOTT, Sean, SULLIVAN, Timothy J, WETHERS, Judith, PARKER, Monica M

    “…Prevalence studies indicate that transmission of drug-resistant HIV has been rising in the adult population, but data from the perinatally infected pediatric…”
    Get full text
    Journal Article